 Connection
Bradley Warady to Dyslipidemias
This is a "connection" page, showing publications Bradley Warady has written about Dyslipidemias.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.857 |
|
|
|
-
Warady BA, Abraham AG, Schwartz GJ, Wong CS, Mu?oz A, Betoko A, Mitsnefes M, Kaskel F, Greenbaum LA, Mak RH, Flynn J, Moxey-Mims MM, Furth S. Predictors of Rapid Progression of Glomerular and Nonglomerular Kidney Disease in Children and Adolescents: The?Chronic Kidney Disease in Children (CKiD) Cohort. Am J Kidney Dis. 2015 Jun; 65(6):878-88.
Score: 0.499
-
Saland JM, Kupferman JC, Pierce CB, Flynn JT, Mitsnefes MM, Warady BA, Furth SL. Change in Dyslipidemia with Declining Glomerular Filtration Rate and Increasing Proteinuria in Children with CKD. Clin J Am Soc Nephrol. 2019 12 06; 14(12):1711-1718.
Score: 0.172
-
Saland JM, Pierce CB, Mitsnefes MM, Flynn JT, Goebel J, Kupferman JC, Warady BA, Furth SL. Dyslipidemia in children with chronic kidney disease. Kidney Int. 2010 Dec; 78(11):1154-63.
Score: 0.091
-
Wyne KL, Fishbane S, Block GA, Warburton K, Berns JS, Neu AM, Warady BA. How should chronic medical therapies be altered with the onset of end-stage renal disease and initiation of dialysis? Semin Dial. 2006 Jan-Feb; 19(1):8-24.
Score: 0.066
-
Nehus E, Furth S, Warady B, Mitsnefes M. Correlates of leptin in children with chronic kidney disease. J Pediatr. 2014 Oct; 165(4):825-9.
Score: 0.030
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|